Key result
Poliomyelitis antistreptococcus serum was discussed as a potential treatment for acute poliomyelitis, but the incomplete abstract reports no quantitative efficacy or safety outcomes.
Why the study?
Does poliomyelitis antistreptococcus serum improve outcomes in patients with acute poliomyelitis?
Does poliomyelitis antistreptococcus serum improve outcomes in patients with acute poliomyelitis?
The abstract discusses the potential value of poliomyelitis antistreptococcus serum in treating acute poliomyelitis based on personal observations and previous reports.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for poliomyelitis antistreptococcus serum in acute disease; controlled trials needed before any clinical consideration.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Edward C. Rosenow (1927) studied Acute poliomyelitis. Poliomyelitis antistreptococcus serum was evaluated. Poliomyelitis antistreptococcus serum was discussed as a potential treatment for acute poliomyelitis, but the incomplete abstract reports no quantitative efficacy or safety outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: